Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

4.98
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
4.50
Today|||52-Week Range
12.15
-46.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.8B

Company Description

OPKO Health, Inc. is a diversified healthcare company. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Contact Information

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami Florida 33137
P:(305) 575-4100
Investor Relations:

Employees

Shareholders

Individual stakeholders41.90%
Mutual fund holders12.57%
Other institutional11.33%

Top Executives

Phillip FrostChairman & Chief Executive Officer
Adam E. LogalChief Financial Officer & Senior Vice President
Jane H. HsiaoVice Chairman & Chief Technology Officer
Steven D. RubinDirector & Executive Vice President-Administration
Charles W. BishopChief Executive Officer-OPKO Renal